Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
European Urology Oncology|March 15, 2022
Health-related Quality of Life with Adjuvant Nivolumab After Radical Resection for High-risk Muscle-invasive Urothelial Carcinoma: Results from the Phase 3 CheckMate 274 TrialJohannes Alfred Witjes, Matthew D Galsky, Jürgen E Gschwend, et al.Plos One|April 13, 2012
Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responsesJoseph T Bruder, Elena Semenova, Ping Chen, et al.The American Journal of Medicine|May 29, 2018
Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery DiseaseRenato D Lopes, Jan Steffel, Manuela Di Fusco, et al.The American Journal of Medicine|August 11, 2020
Corrigendum to "Effectiveness and Safety of Oral Anticoagulants in Adults with Non-valvular Atrial Fibrillation Patients and Concomitant Coronary/Peripheral Artery Disease" American Journal of Medicine 131:09 (2018): 1074-1085.e4Renato D Lopes, Jan Steffel, Manuela Di Fusco, et al.Antimicrobial Agents and Chemotherapy|October 29, 2014
Anti-alpha-toxin monoclonal antibody and antibiotic combination therapy improves disease outcome and accelerates healing in a Staphylococcus aureus dermonecrosis modelJamese J Hilliard, Vivekananda Datta, Christine Tkaczyk, et al.European Journal of Cancer (Oxford, England : 1990)|May 11, 2023
Health-related quality of life with nivolumab plus relatlimab versus nivolumab monotherapy in patients with previously untreated unresectable or metastatic melanoma: RELATIVITY-047 trialDirk Schadendorf, Hussein Tawbi, Evan J Lipson, et al.Science Translational Medicine|March 11, 2016
Staphylococcus aureus α toxin potentiates opportunistic bacterial lung infectionsTaylor S Cohen, Jamese J Hilliard, Omari Jones-Nelson, et al.The Journal of Experimental Medicine|June 27, 2012
Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screeningAntonio DiGiandomenico, Paul Warrener, Melissa Hamilton, et al.Cell|September 21, 2023
Mpox infection protects against re-challenge in rhesus macaquesMalika Aid, Michaela Sciacca, Katherine McMahan, et al.The New England Journal of Medicine|January 5, 2022
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced MelanomaHussein A Tawbi, Dirk Schadendorf, Evan J Lipson, et al.Pageof 6